What does this research mean for the field?

Poor medication adherence in bipolar disorder is associated with specific clinical and sociodemographic factors including younger age, substance use disorders, psychiatric comorbidities, and greater disease severity, although the overall quality of evidence is weak. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim was to identify factors associated with poor medication adherence in individuals with bipolar disorder.

June 12, 2026Open Access

Clinical and Sociodemographic Correlates of Poor Medication Adherence in People With Bipolar Disorder: A Systematic Review and Meta‐Analysis

Key Points

The aim was to identify factors associated with poor medication adherence in individuals with bipolar disorder.
Conducted systematic review and meta-analysis of 19 studies.
Performed random-effects meta-analyses to calculate pooled odds ratios and standardized mean differences.
Registered protocol in the Open Science Framework.
Younger age (SMD = -0.22) and lower education (SMD = -0.34) were linked to poor adherence.
Comorbid generalized anxiety disorder (OR = 3.70) and personality disorders (OR = 5.54) showed strong associations.
Poor adherence correlated with higher global severity (SMD = 0.21) and lower insight (SMD = -0.74).

Abstract

OBJECTIVES: Poor adherence to psychopharmacological treatment may contribute to relapses in bipolar disorder (BD). We performed a systematic review and meta-analysis to identify factors associated with poor adherence in BD. METHODS: The protocol was registered in Open Science Framework Registries (https://doi.org/10.17605/OSF.IO/2KZFJ). We searched main electronic databases through March 2025. Random-effects meta-analyses were performed to obtain pooled odds ratios (ORs) and standardized mean differences (SMDs) for relevant correlates. RESULTS: We included 19 studies. Subjects with poor adherence were more likely to be younger (SMD = -0.22, 95% CI: -0.42--0.02) and to have lower education (SMD = -0.34, 95% CI: -0.55--0.12), and less likely to be in a relationship (OR = 0.54, 95% CI: 0.34-0.86). Moreover, earlier age at onset (SMD = -0.29, 95% CI: -0.53--0.04), psychotic features (OR = 1.58, 95% CI: 1.30-1.92), a history of suicide attempts (OR = 1.36, 95% CI: 1.03-1.78), a higher number of manic (SMD = 0.34, 95% CI: 0.08-0.61) and mixed (SMD = 0.16, 95% CI: 0.03-0.28) episodes, and more hospitalizations (SMD = 0.53, 95% CI: 0.32-0.73) all emerged as correlates of poor adherence. Also, cannabis (OR = 2.34, 95% CI: 1.79-3.07) and alcohol use disorders (OR = 1.71, 95% CI: 1.39-2.12), comorbid generalized anxiety disorder (OR = 3.70, 95% CI: 1.90-7.22), and comorbid personality disorders (OR = 5.54, 95% CI: 1.32-23.15) were associated with poor adherence. Finally, poorly adherent individuals had higher global severity (SMD = 0.21, 95% CI: 0.01-0.41), lower insight (SMD = -0.74, 95% CI: -1.08--0.41), and lower global functioning (SMD = -0.60, 95% CI: -0.87--0.34). No differences were estimated for other variables. CONCLUSIONS: This meta-analysis showed that poor adherence in people with BD is associated with specific correlates. Although evidence was generally weak due to small effect sizes, imprecision, inconsistency, and potential publication bias, our findings highlight the importance of strategies to improve adherence.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper